USD 2.12 trillion
Report ID:
SQMIG35H2249 |
Region:
Global |
Published Date: April, 2025
Pages:
260
|Tables:
128
|Figures:
77
Biotechnology Market size was valued at USD 2.12 trillion in 2023 and is poised to grow from USD 2.39 trillion in 2024 to USD 6.26 trillion by 2032, growing at a CAGR of 12.79% during the forecast period (2025-2032).
Biotech industry is one of the globalized sectors. Investment in business is characterized by greatly diversified economic growth among countries. The expansion of problems such as hepatitis B disease as well as other issues is expected to drive the expansion in this field. The demand for subsistence and agricultural products such as wheat, rice, sugarcane and beans are expected to increase mainly because the population in US, China, and India is on the rise, and this will boost the importance of these products. Furthermore, scientists are involved in wide research and development activities to address problems such as water shortage, low productivity, insect attacks, and limited farmland. Their focus is on the improvement of smart systems and helping the industry by partnering with other organizations. Large scale associations, including government subsidized organizations and other independent communities acting against biotechnology funding, on the other hand, boost financing to R&D and new product development programs.
The ongoing high incidents of either chronic diseases like diabetes or cancers across the globe are expected to increase the demand for biotechnology products in the coming years. Also, the prevalence of type 2 diabetes among many individuals is seeing a growing trend around the world and thus, the market is likely to experience higher margins. The wide range of uses as well as the currently existing demand for highly effective drugs and treatment options, companies that devote themselves to this branch would presumably benefit more.
US Biotechnology Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2025-2032
Global Market Size
USD 2.12 trillion
Largest Segment
Health
Fastest Growth
Agriculture
Growth Rate
12.79% CAGR
To get more reports on the above market click here to Buy The Report
Global Biotechnology Market is segmented by Product Type, Technology, Application, End User and region. Based on Product Type, the market is segmented into Instruments, Reagents, Services and Software. Based on Technology, the market is segmented into Nano Biotechnology, PCR Technology, DNA sequencing, Chromatography, Tissue Engineering and Regeneration, Cell-Based Assays, Fermentation and Others. Based on Application, the market is segmented into Bio-pharmacy, Bio-industrial, Bio-services, Bioinformatics and Bio-agriculture. Based on End User, the market is segmented into Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Instruments and reagents are projected to account for a major chunk of the global biotechnology market share over the coming years. High investments in biotechnology R&D will require researchers to opt for different types of instruments and reagents, which helps this segment bring in major revenue. Growing emphasis on advancements in research will also boost the demand for novel instruments and reagents thereby cementing the dominance of this segment through 2031.
On the other hand, the demand for software and services is slated to increase at a robust pace in the long run. Growing emphasis on technology utilization in the biotechnology market is slated to help this segment boost market growth at a notable CAGR in the future. Increasing need for biotechnology services and software by different healthcare establishments will also help this segment boost its market share.
Red biotechnology holds sway in terms of revenue generation for the global biotechnology market. Red biotechnology refers to any kind of research and development of biotechnology that is aimed at the healthcare and life sciences industry. High investments in medical R&D and rising prevalence of chronic diseases are majorly contributing to the dominance of this segment.
Meanwhile, the demand for green biotechnology is projected to surge at an impressive pace going forward. The adoption of precision and smart farming practices is estimated to bolster the demand for green biotechnology. Growing investments in improving agricultural yield and improve livestock health will also favor biotechnology demand outlook.
To get detailed analysis on other segments, Request For Free Sample Report
Robust investments in medical R&D are contributing to the high market share of North America. Presence of a developed healthcare infrastructure, quick adoption of novel technologies, and presence of key biotechnology companies are also helping this region's dominance. The United States is slated to be the most opportune market for biotechnology companies in this region followed by Canada. Rapidly aging population and rising prevalence of cancer and diabetes are also expected to help boost biotechnology demand outlook in this region.
Meanwhile, the demand for biotechnology is slated to surge at an impressive pace in the Asia Pacific region over the coming years. Growing investments in healthcare infrastructure development and supportive government initiatives to promote biotechnology R&D are also making this region a highly opportune one for biotechnology market players. Japan, China, and India are estimated to be the top markets in this region going forward. Regulatory compliance is projected to be a major concern in this region as regulations vary vastly across the region.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
High Incidence of Chronic Diseases
Rising Demand for Personalized Medicine
Intellectual Property Claim Disputes
Ethical Concerns and Challenges
Request Free Customization of this report to help us to meet your business objectives.
Biotechnology companies should solely focus on perfecting their R&D divisions first to maximize their business scope in the future. Collaborations, mergers, and capital raises are projected to be preferred strategies for incoming biotechnology companies looking to penetrate the market. Use of advanced technologies such as artificial intelligence and machine learning will also present new opportunities for biotechnology market players going forward.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, high prevalence of chronic diseases, growing investments in medical R&D, and high demand for personalized medicine are slated to boost biotechnology market growth. However, ethical concerns, complexity in biomanufacturing, and regulatory compliance are estimated to be the top restraints for biotechnology companies. High investments in medical R&D and quick adoption of novel technologies are key prospects that help North America maintain a dominance stance. Demand for red biotechnology is slated to bring in the most revenue across the study period. Developing synthetic biology products via biotechnology will pay off big time for biotechnology companies in the long run.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 2.12 trillion |
Market size value in 2032 | USD 6.26 trillion |
Growth Rate | 12.79% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Trillion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Biotechnology Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Biotechnology Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Biotechnology Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Biotechnology Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
Biotechnology Market size was valued at USD 1.56 Trillion in 2023 and is poised to grow from USD 1.77 Trillion in 2024 to USD 4.96 Trillion by 2032, growing at a CAGR of 13.71% during the forecast period (2025-2032).
Biotechnology companies should solely focus on perfecting their R&D divisions first to maximize their business scope in the future. Collaborations, mergers, and capital raises are projected to be preferred strategies for incoming biotechnology companies looking to penetrate the market. Use of advanced technologies such as artificial intelligence and machine learning will also present new opportunities for biotechnology market players going forward. 'AstraZeneca (UK) ', 'Gilead Sciences, Inc. (US) ', 'Biogen Inc. (US) ', 'Merck (Germany) ', 'Illumina, Inc. (US) ', 'Novo Nordisk A/S (Denmark) ', 'Thermo Fisher Scientific Inc. (US) ', 'Agilent Technologies, Inc. (US) ', 'Lonza Group AG (Switzerland) ', 'Pfizer Inc. (US) ', 'Bristol-Myers Squibb (US) ', 'Amgen Inc. (US) ', 'AbbVie Inc. (US) ', 'Regeneron Pharmaceuticals, Inc. (US) ', 'Vertex Pharmaceuticals Incorporated (US) ', 'Roche Holding AG (Switzerland) ', 'Johnson & Johnson Services, Inc. (US) ', 'Moderna, Inc. (US) ', 'Bio-Rad Laboratories, Inc. (US) ', 'Qiagen N.V. (Netherlands)'
Incidence of chronic diseases such as cancer and diabetes has increased on a global level. Subsequently the demand for treatment of these diseases is also increasing at a rapid pace and fueling the global biotechnology market growth all over the world.
Synthetic Biology: Biotechnology companies can focus on the rapidly growing popularity of the synthetic biology approach to maximize their revenue generation scope in the long run. From pharmaceuticals to fuels, synthetic biology is an approach that has the potential to revolutionize the world through biotechnology.
Robust investments in medical R&D are contributing to the high market share of North America. Presence of a developed healthcare infrastructure, quick adoption of novel technologies, and presence of key biotechnology companies are also helping this region’s dominance. The United States is slated to be the most opportune market for biotechnology companies in this region followed by Canada. Rapidly aging population and rising prevalence of cancer and diabetes are also expected to help boost biotechnology demand outlook in this region.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35H2249
[email protected]
USA +1 351-333-4748